Archive for April, 2014

#MailOrderWaste & the Need for Medication Disposal Programs

By Stephanie DuBois, Associate Director, Marketing Communications

Earth Day was yesterday and Saturday marks another nationwide Prescription Drug Take-Back Day. While this is a good opportunity for individuals to properly dispose of unused or expired medications at a safe location, consumers need more convenient access to disposal locations more than twice a year. That’s why NCPA members have stepped up to help their patients through the Dispose My Meds™ program. Since its inception in 2009, Dispose My Meds has collected over 200 tons of medications at more than 1,600 participating community pharmacies in 40 states across the country. (Note: opioids and other controlled substances are not allowed.)

Continue reading ‘#MailOrderWaste & the Need for Medication Disposal Programs’

National Prescription Drug Take-Back Day: The Pharmacist’s Role

The following is a guest post from Ginger Skinner of Consumer Reports Best Buy Drugs

Dropping off medicines at a local pharmacy or participating in a medication take-back event is a convenient way for patients to dispose of expired and unused medicines. As a community pharmacist, now is a great time to remind patients to do just that. This Saturday, April 26th, is the 8th National Prescription Drug Take-Back Day, consumers clean out their medicine cabinets of leftover and expired medications can do so at over 4,000 sites across the U.S. This effort is operated by the Drug Enforcement Administration (DEA) and its thousands of state and local law enforcement partners, including many fire and police stations, hospitals, and churches. Since its start, the Take-Back Day initiative has collected over 3.4 million pounds of medication from the public. Continue reading ‘National Prescription Drug Take-Back Day: The Pharmacist’s Role’

Lawmakers Focus on Community Pharmacists’ Generic Drug Payment Concerns

By Kevin Schweers

Two Georgia Republicans—U.S. Reps. Doug Collins and Austin Scott—took for the floor of the U.S. House of Representatives the evening of April 9th to express their strong support for independent community pharmacists and, in particular, the serious problems that they’ve encountered with secretive and often outdated maximum allowable cost (MAC) reimbursement limits set by pharmacy benefit managers (PBMs) for generic drugs in Medicare Part D drug plans. Continue reading ‘Lawmakers Focus on Community Pharmacists’ Generic Drug Payment Concerns’

Search by Categories